Skip to main contentSkip to navigation
Sirius Investors
THC Farmaceuticals, Inc.

THC Farmaceuticals, Inc.

CBDG
OTCHealthcare

CBDG Financial Statements & Analysis

Complete financial statements for CBDG including income statement, balance sheet, and cash flow statement. Analyze CBDG's revenue growth, profit margins, earnings trends, debt levels, and cash flow generation.

TTM figures are calculated by rolling up the last four quarterly filings (income and cash flow summed; balance sheet at period end).

Financial Health Score

Financial Health Score

/100
Unlock score for free

Already registered? Sign in

Income Statement

Revenue
-34.7%
Net Income
112.3%
Gross Margin
-4.1%
Operating Margin
38.1%

Balance Sheet

Current Ratio
-1.1%
Debt to Equity
1.0%
Asset Turnover
-34.6%

Cash Flow

Operating Cash Flow
60.6%
Net Cash Flow
1302.3%
Free Cash Flow
60.6%
Cash Flow to Debt
61.0%

Income Statement Comparison

Revenue & Net Income

Period Comparison

MetricTTM Q1 '22TTM Q2 '22ChangeImpact
Revenue23.00K15.03K34.7%
Gross Profit19.43K12.17K37.4%
Operating Income-71.70K-28.97K59.6%
Net Income-392.64K48.13K112.3%
EPS-0.010.00112.0%
EBITDA-781.13K99.12K112.7%
Gross Margin84.47%80.99%4.1%
Operating Margin-311.70%-192.79%38.1%
Net Income Margin-1706.92%320.29%118.8%
R&D Expenses000.0%

Income Statement Full Table

Free users can view the last 3 periods. Upgrade to see the full history.

Upgrade
MetricTTM Q2 '22TTM Q1 '22TTM Q4 '21TTM Q4 '19TTM Q2 '19
Revenue15.03K23.00K26.75K
Gross Profit12.17K19.43K24.12K
Operating Income-28.97K-71.70K-102.19K
Net Income48.13K-392.64K-407.93K
EPS0.00-0.01-0.01
EBITDA99.12K-781.13K-812.58K
Gross Margin80.99%84.47%90.20%
Operating Margin-192.79%-311.70%-382.09%
Net Income Margin320.29%-1706.92%-1525.27%
R&D Expenses000

Our detailed financial analysis helps investors understand CBDG's business performance, operational efficiency, and financial health through comprehensive financial statement data presented in both quarterly and annual formats.

Track CBDG's financial performance metrics including revenue, gross profit, operating income, net income, total assets, liabilities, shareholders' equity, operating cash flow, and free cash flow with historical comparison and trend analysis.

Financial Metrics

Want to dive deeper into CBDG's financial health? Explore key financial metrics and ratios including profitability, liquidity, efficiency, and valuation metrics.

View Financial Metrics
THC Farmaceuticals, Inc. (CBDG) Financial Statements (2026): Income, Balance Sheet & Cash Flow | Sirius Investors